Neoadjuvant Immunotherapy for Skin Cancer April 18, 2023 The standard of care for patients with locally advanced, resectable head and neck squamous cell carcinomas is surgery and radiation but neoadjuvant immunotherapy is promising for some patients. Pages: 1 2 3 4 5 6 | Single Page
